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Summary
 
Murine phosphatidyl choline (PtC)–specific B cells in normal mice belong exclusively to the
B-1 subset. Analysis of anti-PtC (V
 
H
 
12 and V
 
H
 
12/V
 
k
 
4) transgenic (Tg) mice indicates that ex-
clusion from B-0 (also known as B-2) occurs after immunoglobulin gene rearrangement. This
predicts that PtC-specific B-0 cells are generated, but subsequently eliminated by either apop-
tosis or differentiation to B-1. To investigate the mechanism of exclusion, PtC-specific B cell
differentiation was examined in mice
 
 
 
expressing the X-linked immunodeficiency (
 
xid
 
) muta-
tion. 
 
xid
 
 mice lack functional Bruton’s tyrosine kinase (Btk), a component of the B cell recep-
tor signal transduction pathway, and are deficient in B-1 cell development. We find in C57BL/
6.
 
xid
 
 mice that V
 
H
 
12 pre-BII cell selection is normal and that PtC-specific B cells undergo
modest clonal expansion. However, the majority of splenic PtC-specific B cells in anti-PtC
Tg/
 
xid
 
 mice are B-0, rather than B-1 as in their non-
 
xid
 
 counterparts. These data indicate that
PtC-specific B-0 cell generation precedes segregation as predicted, and that Btk function is re-
quired for efficient segregation to B-1. Since 
 
xid
 
 mice exhibit defective B cell differentiation,
not programmed cell death, these data are most consistent with an inability of PtC-specific B-0
cells to convert to B-1 and a single B cell lineage.
 
A
 
t least two B cell subsets, B-1 and B-2, are present in
the mouse periphery (1–4). One of the most intrigu-
ing aspects of these subsets is that they exhibit different rep-
ertoires (5), presumably reflecting different functions in
the immune system. B-2 cells appear to be responsible for
T cell-dependent responses to exogenous antigens and for
generating memory B cells (4). In contrast, the B-1 subset
harbors a high frequency of cells with specificities to self-
antigens such as phosphatidyl choline (PtC),
 
1
 
 immunoglob-
ulin (rheumatoid factor), DNA, as well as specificities to
common bacterial carbohydrate antigens like phosphoryl-
choline (6–10), and may be involved in T cell-independent
responses to common environmental antigens.
The distinct B-1 and B-2 repertoires are the conse-
quence of different selective pressures (11, 12), but the na-
ture of these differences is not known. Critical to under-
standing how B-1 and B-2 repertoires arise is the relationship
between the cells of these subsets. The more commonly
held view (the lineage hypothesis) is that B-1 and B-2 cells
derive from stem cells committed to one or the other sub-
set before Ig gene rearrangement, thereby constituting two
separate lineages (13–15). An alternative hypothesis (the
induced differentiation hypothesis) is that they derive from
a single lineage, and that an uncommitted B cell is induced
to differentiate to a B-1 cell after Ig gene rearrangement by
interaction with antigen, probably T cell-independent anti-
gens in the absence of T cell help (16, 17). Since by this
hypothesis the majority of splenic B cells are uncommitted,
they are referred to as B-0 cells. Thus, the B-2 cells of the
lineage hypothesis and the B-0 cells of the induced differ-
entiation hypothesis are equivalent and referred to here as
B-0. Each hypothesis predicts a different means of arriving
at distinct B-1 and B-0 repertoires.
We have focused on the differentiation of B cells specific
for the common membrane phospholipid, PtC, as a means
to understand the bases for the repertoire differences be-
tween B-1 and B-0 cells. In normal mice, PtC-specific B
cells appear to be exclusively B-1 (6, 12, 18, 19). They
are driven to undergo considerable clonal expansion from
birth (20, 21), and in normal adults eventually account for
2–10% of the peritoneal B-1 repertoire (6). Many anti-PtC
B cells express V
 
H
 
12 and V
 
k
 
4 rearrangements (11, 22). The
V
 
H
 
12 H chain is restricted to CDR3s of 10 amino acids
with Gly in the fourth position and Tyr, encoded by the
 
1
 
Abbreviations used in this paper:
 
 Btk, Bruton’s tyrosine kinase; dbl, double;
NP, nonproductive; P, productive; PtC, phosphatidyl choline; sIgM, sur-
face IgM; Tg, transgenic.
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first codon of J
 
H
 
1, in the fifth position (referred to as 10/G4)
(11). Selection for B cells of the appropriate gene rear-
rangements occurs at two stages during B cell develop-
ment. The first results in the elimination of most non-10/
G4 V
 
H
 
12 pre-BII cells and in the enrichment of 10/G4
V
 
H
 
12 pre-B cells (23). This is probably due to positive se-
lection of 10/G4 pre-BII cells, and an absence of positive
selection of non-10/G4 pre-BII cells resulting in the death
of the latter. The second stage of selection is at the B cell
stage where 10/G4 V
 
H
 
12 B cells that express the appropri-
ate V
 
k
 
4 L chain and bind PtC undergo antigen-driven
clonal expansion in response to some ubiquitous environ-
mental or self-antigen (24).
To understand the basis for the segregation of PtC-spe-
cific B cells to the B-1 subset, we have generated anti-PtC
transgenic (Tg) mice using the V
 
H
 
12 and V
 
k
 
4 gene rear-
rangements of the anti-PtC lymphoma CH27 (21, 22).
Mice with either the V
 
H
 
12 or the V
 
H
 
12 and V
 
k
 
4 Tgs con-
tinue to segregate PtC-specific B cells to the B-1 subset, in-
dicating that the mechanism of segregation operates after Ig
gene rearrangement (21). We predict that B-0 cells ex-
pressing the combination of V
 
H
 
12 and V
 
k
 
4 are generated
in these Tg mice. Therefore, to achieve segregation, either
PtC-specific B-0 cells are activated and induced to become
B-1 cells (induced differentiation hypothesis), thereby de-
pleting the B-0 subset of this specificity, or they are stimu-
lated by antigen to undergo apoptosis (lineage hypothesis).
To distinguish between these possibilities, we have com-
bined the V
 
H
 
12 and V
 
k
 
4 Tgs (21) with the 
 
xid
 
 mutation
(25, 26). This mutation ablates function of Bruton’s ty-
rosine kinase (Btk) (27–30), resulting in deficiencies in B cell
differentiation (31–33) and responsiveness to T cell-inde-
pendent type II antigens (26). This mutation also blocks
development of a detectable peritoneal B-1 population in
CBA/N mice (34). Analysis of the cellular defect indicates
that signaling through surface IgM (sIgM) fails to drive 
 
xid
 
B cells into cell cycle (35, 36). 
 
xid
 
 B cells do not appear to
be deficient in induction of programmed cell death (36,
37). We demonstrate here that in 
 
xid
 
 mice, V
 
H
 
12 pre-B
cell selection is normal and that PtC-specific B cells un-
dergo modest clonal expansion. However, combining the
V
 
H
 
12 and V
 
k
 
4 Tgs with 
 
xid
 
, we demonstrate that the ma-
jority of splenic PtC-specific B cells fail to segregate to the
B-1 subset and instead have a B-0 phenotype. These data
argue that B-0 cells are an intermediate step in B-1 cell dif-
ferentiation, consistent with the induced differentiation hy-
pothesis and a single lineage of B cells.
 
Materials and Methods
 
Mice.
 
V
 
H
 
12 (6-1) and V
 
k
 
4 Tg mice have been described pre-
viously (21) and are maintained in our colony at the University of
North Carolina by backcrossing to C.B17 mice. Offspring are
identified by PCR analysis of tail genomic DNA as previously
described (21). Double (dbl) Tg mice are generated by the inter-
crossing of 6-1 and V
 
k
 
4 Tg mice. C57BL/6.
 
xid
 
 (B6/xid) mice
were obtained from the National Institutes of Health (Bethesda,
MD) and bred separately with the V
 
H
 
12 and V
 
k
 
4 Tg mice to ob-
tain V
 
H
 
12 and V
 
k
 
4 Tg-
 
xid
 
/
 
xid
 
 mice. These mice were inter-
crossed to obtain V
 
H
 
12/V
 
k
 
4 dbl Tg/
 
xid
 
 mice.
 
PCR Analysis of V
 
H
 
12 CDR3 Sequences.
 
Extraction of geno-
mic DNA, PCR, and cloning of V
 
H
 
12 rearrangements was per-
formed as previously described (20). Clones of V
 
H
 
12 rearrange-
ments were chosen randomly for sequence analysis.
 
Immunofluorescence and Flow Cytometry.
 
The antibodies used
against IgM
 
a
 
 (DS-1), IgM
 
b
 
 (AF6-78), B220 (RA3-6B2), and
CD5 (53-7.3) were obtained from PharMingen (San Diego, CA),
and were fluoresceinated, biotinylated, or conjugated to PE.
CD23 (B3B4) and CD43 (S7) were gifts of Dr. Tom Wald-
schmidt (University of Iowa, Iowa City, IA). In three-color ex-
periments, directly fluoresceinated and PE-conjugated antibodies
were combined with a biotinylated antibody revealed with strepta-
vidin-RED670 (GIBCO BRL, Gaithersburg, MD). To detect PtC-
binding B cells, liposomes encapsulating carboxyfluorescein were
used as previously described (21).
To detect membrane expression of various molecules, single
cell suspensions were prepared in HBSS (without Ca
 
2
 
1
 
, Mg
 
2
 
1
 
, or
phenol red) containing 0.1% sodium azide and 1.0% FCS
(buffer). Cells were incubated with previously determined opti-
mal amounts of antibody in 25–50 
 
m
 
l buffer for 20 min, after
which they were washed three times with buffer and incubated
with second step reagents. After washing as before, the cells were
analyzed using a FACScan (Becton Dickinson, Mountain View,
CA) with acquisition and analysis software from Cytomation, Inc.
(Ft. Collins, CO). All data represent cells that fall within the lym-
phocyte gate determined by forward and 90
 
8
 
 light scatter. 1–5 
 
3
 
10
 
4
 
 cells were analyzed. All contour plots are 5% probability.
 
Results
 
The V
 
H
 
12 Repertoire in C57BL/6 xid/xid (B6/xid) Mice.
 
As a result of positive selection at the pre-B and B cell
stages, mature V
 
H
 
12 B cells in the spleen and peritoneum
are almost exclusively 10/G4 (24). To assess the ability of
 
xid
 
 mice to select V
 
H
 
12 pre-B and B cells, we determined
the ratio of the number of productive (P) V
 
H
 
12 rearrange-
ments to the number of nonproductive (NP) V
 
H
 
12 rear-
rangements (P/NP). In the absence of selection, the P/NP
for any V gene should be 
 
z
 
2.3 (23, 38, 39), assuming that
rearrangement is random. P/NP values 
 
,
 
2.3 would indi-
cate selection against cells expressing a
 
 
 
P
 
 
 
V
 
H
 
12 rearrange-
ment, while a P/NP value 
 
.
 
2.3 would indicate clonal ex-
pansion of B cells with
 
 
 
P
 
 
 
V
 
H
 
12 rearrangements. However,
to independently assess selection at the pre-B and B cell
stages, we calculated both 10/G4 and non-10/G4 P/NP
values. Non-10/G4
 
 
 
P
 
 
 
rearrangements include all V
 
H
 
12 re-
arrangements that are not 10/G4. Since most non-10/G4
rearrangements are eliminated at the pre-BII cell stage (23),
the non-10/G4 P/NP is a measure of pre-BII cell selec-
tion. In the absence of selection, all but a small number of
P
 
 
 
rearrangements will be non-10/G4, and thus, the ex-
pected value for the non-10/G4 P/NP is essentially 2.3
(23). The 10/G4 P/NP is a measure of the extent of clonal
expansion of PtC-specific B cells, since clonal expansion of
PtC-specific B cells will increase the number of 10/G4 re-
arrangements in a given population with a negligible effect
on the number of NP V
 
H
 
12 rearrangements. The 10/G4 
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P/NP is measured to be 
 
,
 
0.05 in the absence of clonal ex-
pansion (23).
To measure the 10/G4 and non-10/G4 P/NPs in 
 
xid
 
mice, V
 
H
 
12-D-J
 
H
 
1 rearrangements from genomic DNA of
bone
 
 
 
marrow, spleen, and peritoneal cells were PCR am-
plified. The amplified DNA was cloned, and clones were
randomly selected for sequencing. As shown in Fig. 1 and
Table 1, the majority of P rearrangements in the bone mar-
row are non-10/G4 (5 out of 8) and the non-10/G4 P/NP
is 0.18, not different from that of wild-type mice, and sig-
nificantly lower than the expected value of 
 
z
 
2.3. This
value is equally low in spleen and peritoneum. Thus, as in
wild-type mice (24), non-10/G4 rearrangements contrib-
ute little to the central and peripheral repertoires, indicating
that pre-B cell selection is unaffected by the 
 
xid
 
 mutation.
Clonal expansion of 10/G4 B cells occurs in 
 
xid
 
 mice,
but to a lesser extent than in wild-type mice. Three out of
eight P
 
 
 
V
 
H
 
12 rearrangements in the bone marrow are 10/
G4, and the 10/G4 P/NP (0.11) is one-third that seen in
wild-type mice (Fig. 1 and Table 1). However, the fre-
quency of 10/G4
 
 P 
 
rearrangements is higher than that ob-
served in the absence of selection and clonal expansion (0
of 22 in 
 
m
 
MT mice) (23), indicating that 10/G4 P rear-
rangements are enriched in 
 
xid
 
 bone marrow. Enrichment
is greater in the spleen and particularly the peritoneum,
 
Table 1.
 
V
 
H
 
12 P/NP Values for B6/xid Bone Marrow, Spleen, and Peritoneum
 
*
 
P (10/G4)
 
‡
 
NP
P/NP OVERALL P/NP
10/G4 Non-10/G4 10/G4 Non-10/G4
Bone marrow
Mouse 1 5 (2) 6 0.33 0.50 0.11 (0.33)§ 0.18 (0.22)
Mouse 2 3 (1) 22 0.05 0.091
Spleen
Mouse 1 4 (4) 19 0.21 0 0.29 (1.88) 0.029 (0.13)
Mouse 2 7 (6) 15 0.40 0.067
Peritoneum
Mouse 2 10 (10) 2 5 0 10 (32) 0.50i
Mouse 3 11 (10) 0
*All P rearrangement data were taken from Fig. 1.
‡The total number of P rearrangements is followed in parentheses by the number of P rearrangements that are 10/G4.
§The 10/G4 and non-10/G4 P/NP values for wild-type mice are given in parentheses and are taken from studies by Ye et al. (23, 24).
iNo non-10/G4 P rearrangements were observed in the peritonea of wild-type mice and therefore a non-10/G4 P/NP could not be calculated.
Figure 1. CDR3 amino acid sequences of VH12-D-JH1 rearrangements
from bone marrow, spleen, and peritoneum of B6/xid mice. DNA was
extracted from tissues of individual mice and either one or two separate
PCR reactions were performed as indicated. PCR products were cloned
and transfected, and individual colonies were chosen randomly for se-
quence analysis. The number of colonies that gave the identical nucle-
otide sequence is given in the second column. Asterisks indicate the
clones originating from separate PCR that have identical nucleic acid se-
quences across the VH12-D-JH1 junction. The final column indicates the
number of CDR3 amino acids encoded by each rearrangement. Whether
or not a Gly is encoded at position 4 of CDR3 (G4) is indicated for
clones with a length of 10 amino acids.1328 Antiphosphatidyl Choline B Cell Differentiation in xid Mice
where almost every P rearrangement is 10/G4. The 10/G4
P/NP is smaller than that observed in wild-type mice, re-
flecting a more modest clonal expansion. Nevertheless,
clonal expansion of 10/G4 VH12 peripheral B cells, pre-
sumably because they are PtC-specific, occurs in B6/xid
mice.
Ig Tg/xid Mice Can Develop B-1 Cells. To determine the
effect of the xid mutation on B-1 cell development, we
combined the xid mutation with the VH12 and Vk4 trans-
genes, since these transgenes exert a strong positive influ-
ence on B-1 cell development (21). We find that 6-1/xid
mice have approximately one-fourth the number of splenic
B cells found in 6-1 mice (Table 2). Thus, as expected (40),
the  xid mutation limits B cell development in this Tg
model. B cells were stained for expression of a number of
cell surface markers that distinguish B-1 and B-0 cells. B-1
cells are defined as CD431, CD232, B220lo, IgMhi, and
they may or may not express CD5. B-0 cells, on the other
hand, are defined as CD432, CD231, B220hi, and IgMlo,
and they never express CD5. Shown in Fig. 2, A and B,
and as we have previously published (21), a large fraction of
the splenic B cells in 6-1 and dbl Tg mice are B-1 cells, i.e.,
CD51, CD232, B220lo, and IgMhi. A smaller number of B
cells in these Tg mice are B-0, i.e., CD52, CD231, B220hi,
and IgMlo. These cells in 6-1 mice are predominantly PtCneg
(see below).
In contrast to their non-xid counterparts, B-1 cells in the
spleens of Tg/xid mice are consistently a minority. Only
15–25% are B-1 cells with a CD431, CD232, B220lo, and
IgMhi phenotype (Table 2 and Fig. 3). Most of these cells
in 6-1/xid mice are CD52, whereas most in dbl Tg/xid are
CD51 (follow the B220lo population in Fig. 3 A). The ma-
jority of the B cells in these Tg/xid mice have a B-0 phe-
notype, as they are CD52, CD432, CD231, B220hi, and
IgMlo. Cells with the B-1 phenotype are also evident in the
peritoneum (CD431, CD232, B220lo, and IgMhi; Fig. 4, A
and B), but their number is considerably lower than that in
6-1 and wild-type mice (Table 2). Thus, xid mice can gen-
erate B-1 cells, but the positive pressure exerted on B-1 cell
development by the VH12 and Vk4 transgenes is partially
negated by the xid mutation.
Segregation of PtC-specific B Cells to the B-1 Subset in xid
Spleens Is Impaired. To determine the effect of xid on the
segregation of PtC-specific B cells, we compared the phe-
notype of PtC-specific B cells from Tg/xid and Tg non-xid
mice. PtC-specific cells can be detected by flow cytometry
using as a probe fluorescein-encapsulating liposomes that
contain PtC as a membrane constituent (6). As previously
published (21), all of the B-1 cells of 6-1 and dbl Tg mice
bind liposomes (CD232, CD431 cells in Fig. 2 C).
Dbl Tg mice have a liposome-binding population that is
intermediate in staining (liposomeint) (Fig. 2 C). These cells
have a B-0 phenotype since they are CD231, IgMlo, and
B220hi (Fig. 2 C, and follow the CD231 population in Fig.
2, A and B). The liposomeint B-0 cells account for 10–30%
of the B cells in a dbl Tg spleen. These cells were not pre-
viously detected probably because the liposome probe used
in this study is much brighter than that used in our earlier
study (21). Since these cells likely express the VH12 and
Vk4 Tgs, we conclude that they are liposomeint by virtue
of the fact that they are IgMlo. We speculate that they con-
stitute the PtC-specific B-0 cells predicted to undergo ei-
ther programmed cell death or conversion to B-1 to
achieve segregation of this specificity (21). A smaller num-
ber of these cells (5.6% in Fig. 2 C) appear to be present in
6-1 mice. 
The xid mutation affects the relative proportions of the
PtC-specific B-0 and B-1 subsets. The number of liposome
binding cells in 6-1/xid is z10% of that in 6-1 mice. Al-
though their number is small, the liposome-binding B cells
appear to be equally divided between the liposomeint B-0
(CD231, CD432) and liposomebri B-1 (CD232, CD431)
populations (Fig. 3 C). The presence of two subsets of
PtC-specific B cells in xid mice is more apparent in dbl Tg/
xid mice, since the addition of the Vk4 transgene increases
the number of B cells present in the xid spleen fourfold
(Table 2 and Fig. 3 C). In these mice, nearly two-thirds of
the PtC-specific B cells are liposomeint B-0 cells, as they are
Figure 2. Analysis of spleen
cells from 6-1 and dbl Tg mice.
Spleen cells from 6-1 and dbl Tg
mice were stained with FITC-
conjugated anti-B220, PE-con-
jugated anti-IgM, and the bioti-
nylated antibody indicated on
the left (A and B). For C, cells
were stained with carboxyfluo-
rescein-encapsulating liposomes,
PE-conjugated anti-B220, and the
biotinylated reagent on the left.
The biotinylated antibodies were
visualized with PE-conjugated
streptavidin. 10,000–20,000 cells
were analyzed. Percentages are
of the B2201 cells.1329 Clarke and Arnold
CD432 and CD231 (Fig. 3 C) and B220hi and IgMlo (fol-
low the CD231 population in Fig. 3, A and B). The remain-
der of the PtC-specific B cells are liposomebri B-1 cells that
are CD431 and CD232 (Fig. 3 C), and B220lo and IgMhi
(follow the CD431 population in Fig. 3, A and B). Since
most IgMhi B cells in these mice are CD51 (Fig. 3, A and
B), most of the liposomebri B-1 cells are CD51. This dra-
matic shift in the distribution of liposome binding cells
from B-1 to B-0 in xid mice indicates that the xid mutation
impairs the segregation of PtC-specific B cells to the B-1
subset.
Segregation of PtC-specific B Cells to the B-1 Subset Is Largely
Intact in xid Peritonea. The majority of B-1 cells in normal
adult mice are located in the peritoneum. B6/xid mice
have z40% of the number of B cells in the peritoneum,
and on average 15% are CD51 and CD431, a much smaller
percentage than in wild-type mice (Table 2). In addition,
2–4% of peritoneal B cells bind liposomes. Thus, xid mice
are not devoid of peritoneal B-1 cells or of liposome-bind-
ing B cells. This provides an explanation for our observa-
tion of enrichment of 10/G4 rearrangements in the perito-
nea of B6/xid mice (Fig. 1 and Table 1). This is different
from previous reports that xid mice lack peritoneal B-1
cells. This is likely due to background genetic differences
between B6/xid mice and the CBA/N mice used in previ-
ous studies (34).
Essentially all peritoneal B cells in 6-1 mice are liposomebri
B-1 cells (Fig. 4 C and Table 2), as previously reported
(21). They are CD232, CD431, B220lo, and IgMhi (Fig. 4,
A and B). Approximately 80% of liposome binding cells are
CD51. In contrast to the spleen, nearly all of the peritoneal
B cells in 6-1/xid and dbl Tg/xid mice are liposomebri B-1
cells (Fig. 4 C). The number of PtC-specific B cells in 6-1/
xid mice is almost 10% of that in 6-1 mice, whereas that in
dbl Tg/xid mice is nearly 30% (Table 2). Thus, the combi-
nation of these two transgenes does not increase the num-
ber of PtC-specific B cells in the peritoneum as dramati-
cally as it does in the spleen (3.53 versus 463). The
liposomebri cells in 6-1/xid and dbl Tg/xid mice are mostly
CD232 (Fig. 4 C) and B220lo and IgMhi (Fig. 4, A and B).
Table 2. B Cell Subpopulations in the Spleen and Peritoneum of VH12 Tg Mice
Genotype n
Total
lymphs*
% IgM1
B cells
Total
B cells‡
Percentage of B cells that are
% CD51
Total
CD51‡ % CD231
Total
CD231‡ % CD431
Total
CD431‡ % Lipo1
Total
Lipo1‡
Spleen cells
6-1 9 4.8 6 24.9  6 11.6  6 46.2  6 5.2  6 35.4  6 4.1  6 35.9  6 4.6  6 40.1  6 5.4  6
1.64 7.91 6.38 18.8 4.6 9.9 1.3 14.3 4.2 14.5 4.8
6-1/xid 7 2.7  6 9.2  6 2.7  6 12.6  6 0.3  6 64.9  6 1.8  6 11.1  6 0.3  6 8.8  6 0.2  6
0.6 3.2 0.9 7.9 0.2 4.4 0.5 3.8 0.1 2.0 0.1
dbl Tg/xid 5 4.3 6 25.3 6 11.1 6 11.3 6 1.1 6 60.9 6 6.5 6 8.4 6 0.8 6 84.3 6 9.3 6
1.6 7.7 5.3 3.0 0.4 11.1 2.9 5.0 0.4 8.7 4.4
Normal 8 10.4 6 56.7 6 60.5 6 10.4 6 5.9 6 79.9 6 40.3 6 9.3 6 5.8 6 0.3 6 0.2 6
5.7 5.5 35.3 4.4 3.8 10.0 24.7 2.2 4.3 0.3 0.39
B6.xid 7 5.8 6 48.7 6 31.2 6 13.3 6 2.9 6 73.4 6 23.6 6 13.5 6 3.4 6 0.6 6 0.1 6
3.1 14.0 21.4 14.6 2.5 8.3 16.2 9.1 1.9 1.2 0.1
Peritoneal cells
6-1 6 3.1 6 86.3 6 27.1 6 83.7 6 22.4 6 0.7 6 0.2 6 90.8 6 25.0 6 94.3 6 21.7 6
0.9 5.0 8.9 5.9 6.4 0.4 0.1 6.4 9.7 7.3 8.0
6-1/xid 5 0.6 6 31.2 6 2.1 6 54.7 6 0.9 6 10.1 6 0.3 6 73.4 6 1.9 6 91.3 6 1.7 6
0.3 16.7 1.8 19.5 0.8 7.4 0.3 25.4 1.8 2.8 1.6
dbl Tg/xid 3 0.9 6 65.7 6 6.1 6 71.4 6 4.3 6 11.4 6 0.7 6 57.3 6 2.5 6 96.3 6 6.0 6
0.4 11.9 3.2 10.5 2.3 6.3 0.7 27.2 0.9 5.4 3.3
Normal 6 2.2 6 78.0 6 17.1 6 43.4 6 7.7 6 12.6 6 2.3 6 69.9 6 10.0 6 4.3 6 0.8 6
0.4 4.3 3.0 17.3 3.5 4.2 0.8 14.6 4.3 1.4 0.3
B6.xid 6 1.2 6 55.8 6 6.9 6 14.3 6 0.9 6 42.9 6 2.9 6 15.3 6 1.0 6 3.6 6 0.4 6
0.5 10.6 3.7 13.5 0.6 12.3 1.9 3.8 0.5 1.6 0.2
*3107 for spleen cells and 3106 for peritoneal cells.
‡3106 for spleen cells and 3105 for peritoneal cells.
§Standard deviation.1330 Antiphosphatidyl Choline B Cell Differentiation in xid Mice
About half express CD5 (Fig. 4, A and B), but only about
one-third express CD43, giving them a somewhat unusual
phenotype relative to those in 6-1 mice. Thus, the perito-
neum contains PtC-specific B-1 cells and few, if any, of the
PtC-specific B-0 cells that predominate in the spleen.
Discussion
We demonstrate here that xid mice can generate PtC-
specific B cells. Although their number is small in non-Tg
xid mice, when they are provided the VH12 and Vk4 Tgs,
which encode anti-PtC antibodies (11) and exert strong se-
lective pressure on B-1 cell generation and clonal expan-
sion (21), their numbers increase substantially. However,
two-thirds of the splenic PtC-specific B cells in 6-1/xid
and dbl Tg/xid mice are B-0. There appears to be an
equivalent but smaller B-0 population in dbl Tg non-xid
mice. Thus, the VH12 and Vk4 transgenes reveal a deficit
in the ability of xid mice to segregate PtC-specific B cells to
the B-1 subset, indicating a role for Btk in this process.
That some PtC-specific B cells are B-1 indicates that either
the mutant Btk has residual function, or that its function is
compensated for by other signals, as may occur for others
of its functions (31, 41). These data establish that PtC-spe-
cific B-0 cells are generated, and that segregation to B-1 is
achieved by their subsequent elimination, consistent with
our previous conclusion that PtC-specific B cells segregate
to the B-1 subset by a mechanism operating after Ig gene
rearrangement (21).
xid mice are also deficient in B-1 cell clonal expansion.
The large number of the PtC-specific B-1 cells in 6-1 mice
is due to clonal expansion (21); 6-1 mice are free to use the
endogenous Vk repertoire and the majority of the develop-
ing B cells will be PtCneg. Indeed, at birth only 4% of 6-1
splenic IgM1 cells are liposome binding. But clonal expan-
sion is so significant that by day 6 .80% of the splenic
IgM1 cells are liposome-binding B-1 cells. 6-1/xid mice
generate B-1 cells, but the fact that their numbers remain
small in adult mice indicates that these cells are unable to
undergo significant clonal expansion. This is corroborated
by the analysis of 10/G4 rearrangements in B6/xid mice;
the 10/G4 P/NP in the spleens and peritonea of B6/xid
mice, although high, is lower than in wild-type mice, indi-
cating modest clonal expansion of PtC-specific B cells (Ta-
ble 1). Thus, B-1 cell clonal expansion is impaired in xid
mice, consistent with the known function of Btk in IgM-
mediated signaling (35, 36). This defect is probably a major
contributor to the absence of detectable numbers of B-1
cells in xid mice. Larger numbers of PtC-specific B-1 cells
are seen in dbl Tg/xid mice, but this would not require
clonal expansion, since most newly generated B cells will
express both Tgs and bind PtC.
Segregation of B cells to the B-1 subset must be antigen
driven, as PtCneg VH12- or Vk4-expressing B cells are B-0
in 6-1 and Vk4-only Tg mice (21). Although the identity
of the antigen that drives segregation is not known, it is not
likely that the number of cells in Tg/xid mice exceeds its
availability; dbl Tg/xid have only 1.5 times the number of
Figure 3. Analysis of spleen cells from VH12 Tg/xid mice. Spleen cells
from 6-1/xid and dbl Tg/xid mice were stained as described in the legend
to Fig. 2. As a control and for reference, analysis of 6-1 mice is included.
Percentages are of B2201 cells.1331 Clarke and Arnold
PtC-specific B cells as 6-1 mice, where segregation is in-
tact, and 6-1/xid mice have only 4% the number (Table 2).
Thus, the defect in segregation is likely to be related to the
responsiveness of PtC-specific B cells to antigen, consistent
with the known function of Btk in IgM mediated signal
transduction. This leaves two possible mechanisms; either
PtC-specific B-0 cells are eliminated by apoptosis after
stimulation by antigen, or they convert to B-1 cells.
Signaling of programmed cell death through sIgM in xid
B cells appears to be intact. Anti-IgM stimulation induces
xid B cells to undergo apoptosis as it does wild type B cells
(36). In addition, xid B cells are less resistant to radiation
induced apoptosis (37), indicating that programmed cell
death proceeds normally, but that these cells are deficient at
transducing environmental signals to turn off the cell death
program. Moreover, xid mice are not autoimmune, argu-
ing that negative selection of autoreactive B cells is normal
in these mice. In fact, the xid mutation prevents the devel-
opment of autoimmunity in New Zealand black mice (42,
43). These findings cast doubt on apoptosis as the mecha-
nism of segregation to B-1.
On the other hand, it is well established that the xid mu-
tation affects B cell differentiation. xid mice are unable to
respond to TI-2 antigens and have impaired responses to
some T cell-dependent antigens, particularly at suboptimal
doses (26), and they are unable to generate a normal num-
ber of peritoneal B-1 cells (34). Even naive B-0 cells appear
to not differentiate fully, as they do not downregulate sIgM
to wild type levels (44, 45). xid B cells, in cotransfer exper-
iments with non-xid B cells, are at a competitive disadvan-
tage in survival (32), and are similarly disadvantaged in xid
heterozygous female mice (33). Studies of the biochemical
defect in xid B cells indicate that xid B cells fail to enter cell
cycle and differentiate upon anti-IgM signaling due to a
deficiency in cyclin induction (46). Therefore, we propose
that PtC-specific B-0 cells in xid mice bind antigen, but are
unable to differentiate in response to it, and consequently
remain B-0. This would place B-0 as an intermediate stage
in B-1 cell differentiation.
This mechanism is consistent with the induced differen-
tiation hypothesis in which commitment to the B-1 lineage
occurs after Ig gene rearrangement, is dependent on the
specificity of the B cell, and follows antigen stimulation. It
is incompatible with the two-lineage model of B cell de-
velopment, which requires commitment to one cell lineage
or the other before Ig gene rearrangement, and which does
not accommodate movement of cells from one subset to
the other. Thus, these data argue for a single B cell lineage
that can give rise to B-1 cells upon activation. An implica-
tion of this conclusion is that the B-1 repertoire includes
only antigen-selected B cells, and that at no time is it
equivalent to the B-0 repertoire.
The induced differentiation hypothesis offers an explana-
tion for the existence of the liposomeint B-0 population in
non-xid dbl Tg mice. We suggest that these cells are newly
generated B-0 cells that have not yet converted to B-1, ei-
ther because the large number of PtC-specific B cells pro-
duced by the bone marrow reveals a population that is nor-
Figure 4. Analysis of peritoneal cells from VH12 Tg mice. Cells were
stained as described in Fig. 2. Percentages are of B2201 cells.1332 Antiphosphatidyl Choline B Cell Differentiation in xid Mice
mally too small to detect, or because the number produced
exceeds the available antigen, leaving PtC specific B-0 cells
unconverted for an extended length of time. Consistent
with these possibilities is that there are fewer liposomeint
cells in 6-1 mice (Fig. 2 C) in which the production rate of
PtC-specific B cells is lower than in dbl Tg mice because of
the available use of multiple Vk genes.
The proposal that B-1 cells derive from B-0 cells after
antigen stimulation is consistent with the findings of Ying-zi
et al. (47), demonstrating that stimulation of B-0 cells in
vitro with anti-m and IL-6 induces a B-1 cell phenotype
(i.e., CD51, CD232, IgDlo, B220lo). It is also consistent
with in vivo studies indicating that the formation of the B-1
subset is dependent on the action of coreceptors that deliver
activation signals in concert with surface IgM, as well as on
the presence of an intact signal transduction pathway from
surface IgM. For example, mice deficient in the IgM core-
ceptor CD19 lack B-1 cells, whereas mice that overexpress
CD19 have large numbers of B-1 cells (48–50). Likewise,
mice deficient in the complement receptor CD21 lack B-1
cells (51). Both these receptors amplify the IgM-mediated
signal delivered by antigen and play important costimula-
tory roles in responses to T cell-dependent antigens (48, 49,
51, 52). Deficiencies in the cytoplasmic protein kinases Vav
and protein kinase C–bI/II (PKC-bI/II) also result in the
absence of B-1 cells (53–55), and deficiency in phosphatase
SHP-1 results in an excessive number of B-1 cells (56).
Like Btk, these molecules are involved in signal transduc-
tion from IgM. Both Vav- and PKC–bI/II-deficient mice
also exhibit impaired responses to antigen (53, 54), further
evidence that signals initiated by IgM are essential for B-1
cell formation. Thus, the same signaling pathways used to
respond to antigen are required for the generation of B-1
cells, consistent with an essential role for antigen in B-1 cell
formation and the induced differentiation hypothesis.
Based on our findings with xid mice, we predict that PtC-
specific B cells in mice deficient for these receptor and sig-
nal transduction molecules will be similarly impaired in
their ability to segregate PtC-specific B cells to B-1. In-
deed, recent analysis indicates that PtC-specific B cells in
dbl Tg, CD19-deficient mice are B-0 (Rickert, R., and
S.H. Clarke, unpublished observation).
It is notable that PtC-specific B-0 cells are dominant in
the spleen and lymph nodes (data not shown), but not in
the peritoneum of dbl Tg/xid mice. This is most likely an
indication that PtC-specific B cells home to the perito-
neum only after differentiation to a B-1 cell. Since PtC-
specific B cells in xid Tg mice are deficient in signal trans-
duction, they remain in the spleen and lymph nodes as B-0
cells. The number of B cells in the peritoneum of dbl Tg/
xid mice is nearly as low as it is in 6-1/xid mice, suggesting
that only differentiated B-1 cells are able to migrate to the
peritoneum, consistent with this possibility. However, it
cannot be excluded that peritoneal B cells are more able to
overcome the deficit in signal transduction because of some
unique aspect of the peritoneal microenvironment, such as
antigen or cytokine availability. Such factors might over-
come the absence of wild-type Btk, thereby permitting a
greater degree of differentiation in the peritoneum than
anywhere else. Regardless of the reason, the peritoneum is
an environment in which segregation is largely intact in xid
mice.
This analysis also indicates that pre-B cell selection re-
sulting in the loss of most VH12 pre-BII cells and conse-
quent enrichment for VH12 10/G4 rearrangements is nor-
mal in xid mice. This is in accord with the findings that
pre-B cell proliferation and production is normal in xid
mice (57), and that a defect is not observed until the IgM1
stage, as evidenced by the observation that xid B cells are at
a survival disadvantage relative to non-xid B cells in xid/1
female mice (33). Thus, pre-B cell development is not
measurably affected by the xid mutation, as others have
noted previously (32, 33, 47), in contrast to Btk deficien-
cies in humans (58).
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